GUC Contingent Payment Obligations up to $7.1M
Company: Core Scientific
The claim, verbatim
Unsecured creditors receive contingent rights to additional new common equity, capped at $7.1 million of plan value, based on share-price performance over an 18-month testing period after the Effective Date, payable within 45 days of the testing date and extinguished if shares trade above plan equity value for 20 of 30 trading days.
Source (primary)
core-scientific 8-K exhibit (d666256dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-15)Live source ↗
Quote: “The "GUC Contingent Payment Obligations Maximum Amount" are New Common Interests with an aggregate value, based on Plan Value, equal to $7,100,000.”
How we checked this
Checked on November 16, 2026. The cited source supports every part of this claim.
The supplement describes the GUC Contingent Payment Obligations with a $7.1 million cap, an 18-month testing period, payment within 45 days, and extinguishment on 20-of-30-day trading above plan value.
Confirmed in the source:
- Class 8A unsecured creditors receive contingent rights to additional new common equity
- The rights are capped at $7.1 million of plan value
- The testing period runs 18 months from the Effective Date
- The payout is based on the trading price of the distributed equity
- The rights are payable within 45 days after the testing date
- The rights are extinguished if the equity trades above the plan equity value on 20 trading days within any 30-day trading period
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523305983/d666256dex992.htm) in full (589,421 characters, retrieved November 15, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d666256dex992.htm)
Quote: “The "GUC Contingent Payment Obligations Maximum Amount" are New Common Interests with an aggregate value, based on Plan Value, equal to $7,100,000.”